Orange Book product · Brand (NDA)

FOCINVEZ

FOSAPREPITANT DIMEGLUMINE

Brand (NDA)NDA 216686RX STERISCIENCE

Aug 22, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Aug 22, 2023
2 yr 10 mo ago
Today
Patent 11065265 expires
Listed drug product patent expiration.
Jan 11, 2039
in 12 yr 9 mo
Patent 12042504 expires
Listed drug product patent expiration.
Jan 11, 2039
in 12 yr 9 mo

Active ingredient

FOSAPREPITANT DIMEGLUMINE

Strength

EQ 150MG BASE/50ML (EQ 3MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 216686

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
11065265	Jan 11, 2039	in 12 yr 9 mo	Product
12042504	Jan 11, 2039	in 12 yr 9 mo	Product